Johnson & Johnson MedTech, the medical device division of healthcare giant Johnson & Johnson, will discuss the future of surgical robotics at October's RoboBusiness conference. Tom Salemi, Editorial Director of DeviceTalks, will interview J&J MedTech's Hani Abouhalka on robotic and digital surgery advancements.

As Company Group Chairman of Robotics & Digital Surgery, Abouhalka leads strategy for J&J MedTech's surgery portfolio. This includes Biosense Webster's cardiac arrhythmia devices, CERENOVUS' stroke treatment offerings, and vision technologies from Johnson & Johnson Vision.

With over 23 years at J&J, Abouhalka has extensive experience across medical devices, including roles in EMEA strategy, emerging markets, and operations. His business acumen will provide valuable insights into robotic surgery's continued evolution and expansion.

Abouhalka's discussion comes as surgical robotics garners increasing attention and investment within healthcare. As a dominant player, J&J MedTech's efforts signal the field's tremendous growth potential and benefit to patients worldwide.

RoboBusiness 2022 in Santa Clara convenes leaders across commercial robotics for talks, demos, networking and more. The co-located Field Robotics Engineering Forum covers dynamic outdoor robots, while DeviceTalks West focuses on medical technologies.

Speakers include Exotec Solutions' Romain Moulin, Agility Robotics' Jonathan Hurst, Formant's Jeff Linnell, Plus One Robotics' Erik Nieves, and over 60 others. Attendees can also see the latest innovations, connect with top companies, and catch startup pitch competitions.

Hani Abouhalka's insights will provide a unique view into the medical robotics landscape and J&J's strategy. As a pioneering healthcare firm, their advances in surgical systems may change patient care as AI and robotics continue accelerating.